Skip to main content
HR 554 117th Congress House Health Abortion Drug safety, medical device, and laboratory regulation Health information and medical records Health personnel Health technology, devices, supplies Marketing and advertising Prescription drugs

SAVE Moms and Babies Act of 2021

Introduced: February 4, 2021 Introduced by: Latta, Robert E. Republican · Ohio See on congress.gov
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 2, 2021
Referred to the Subcommittee on Health.
Jan 28, 2021
Introduced in House
Jan 28, 2021
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Support And Value Expectant Moms and Babies Act of 2021 or the SAVE Moms and Babies Act of 2021

This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved.

Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner.

The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner to also act as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient.

The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

What's happening now February 2, 2021

Referred to the Subcommittee on Health.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 112
R
Finstad, Brad
Minnesota · Dec 1, 2022
BRADY, KEVIN
· Nov 7, 2022
R
Fallon, Pat
Texas · Nov 7, 2022
R
Pfluger, August
Texas · Nov 7, 2022
R
Issa, Darrell
California · Sep 30, 2022
R
Stauber, Pete
Minnesota · Sep 30, 2022
R
Crenshaw, Dan
Texas · Jul 26, 2022
Jacobs, Chris
· May 17, 2022
R
Hill, J. French
Arkansas · May 12, 2022
Johnson, Bill
· Apr 7, 2022
Walorski, Jackie
· Apr 7, 2022
CHABOT, STEVE
· Mar 30, 2022
R
Letlow, Julia
Louisiana · Mar 30, 2022
R
Cline, Ben
Virginia · Feb 4, 2022
R
Franklin, Scott
Florida · Feb 4, 2022
R
Rutherford, John H.
Florida · Feb 4, 2022
R
Aderholt, Robert B.
Alabama · Jan 10, 2022
R
Ellzey, Jake
Texas · Jan 10, 2022
R
Harshbarger, Diana
Tennessee · Jan 10, 2022
R
Hudson, Richard
North Carolina · Jan 10, 2022
R
Miller-Meeks, Mariannette
Iowa · Jan 10, 2022
R
Miller, Mary E.
Illinois · Nov 15, 2021
R
Palmer, Gary J.
Alabama · Nov 15, 2021
McKinley, David
· Oct 27, 2021
R
Fitzgerald, Scott
Wisconsin · Oct 12, 2021
R
Griffith, H. Morgan
Virginia · Jul 1, 2021
R
Estes, Ron
Kansas · Jun 24, 2021
R
Gosar, Paul A.
Arizona · Jun 24, 2021
R
Moolenaar, John R.
Michigan · Jun 24, 2021
R
Scott, Austin
Georgia · Jun 24, 2021
R
Emmer, Tom
Minnesota · Jun 16, 2021
McCarthy, Kevin
· May 12, 2021
R
Clyde, Andrew S.
Georgia · Apr 20, 2021
R
Turner, Michael R.
Ohio · Mar 26, 2021
Fortenberry, Jeff
· Mar 9, 2021
R
Graves, Sam
Missouri · Mar 9, 2021
R
McClain, Lisa C.
Michigan · Mar 9, 2021
R
Moore, Blake D.
Utah · Mar 3, 2021
R
Loudermilk, Barry
Georgia · Feb 25, 2021
R
Stefanik, Elise M.
New York · Feb 25, 2021
R
Cloud, Michael
Texas · Feb 4, 2021
R
Fulcher, Russ
Idaho · Feb 4, 2021
Keller, Fred
· Feb 4, 2021
R
Perry, Scott
Pennsylvania · Feb 4, 2021
R
Allen, Rick W.
Georgia · Jan 28, 2021
R
Arrington, Jodey C.
Texas · Jan 28, 2021
R
Babin, Brian
Texas · Jan 28, 2021
R
Baird, James R.
Indiana · Jan 28, 2021
R
Banks, Jim
Indiana · Jan 28, 2021
R
Biggs, Andy
Arizona · Jan 28, 2021
Page 1 of 3 Next
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 554: SAVE Moms and Babies Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-554/
MLA
"H.R. 554: SAVE Moms and Babies Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-554/.
Bluebook (legal)
H.R. 554, 117th Cong. (2026), https://openamerica.io/bill/117-HR-554/.
Markdown link
[H.R. 554: SAVE Moms and Babies Act of 2021](https://openamerica.io/bill/117-HR-554/)
Report a problem